Precigen (PGEN) Capital Expenditures (2012 - 2026)

Precigen (PGEN) has 15 years of Capital Expenditures data on file, last reported at $198000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 68.17% year-over-year to $198000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 146.37% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 485.04% from the prior year.
• Capital Expenditures for Q1 2026 stood at $198000.0, up from $18000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for PGEN reached as high as $4.6 million in Q3 2022 and fell as low as -$7.2 million in Q4 2024.
• Historically, Capital Expenditures has averaged $472000.0 across 5 years, with a median of $231000.0 in 2023.
• On a YoY basis, Capital Expenditures climbed as much as 18029.17% in 2024 and fell as far as 9720.0% in 2024.
• Year by year, Capital Expenditures stood at $53000.0 in 2022, then soared by 41.51% to $75000.0 in 2023, then slumped by 9720.0% to -$7.2 million in 2024, then surged by 100.25% to $18000.0 in 2025, then soared by 1000.0% to $198000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $198000.0 in Q1 2026, $18000.0 in Q4 2025, and $1.7 million in Q3 2025.